Heart failure is a clinical syndrome that appears as a consequence of a structural disease, and the most common cause of left ventricular systolic dysfunction results from myocardial ischemia. Cardiac remodeling and neuroendocrine activation are the major compensatory mechanisms in heart failure. The main objective of the study is to identify the association between serum biomarkers illustrating the extent of myocardial necrosis (highly sensitive troponin assays), left ventricular dysfunction (NT-proBNP), and systemic inflammatory response (illustrated via serum levels of hsCRP and interleukins) during the acute phase of a myocardial infarction, and the left ventricular remodeling process at 6 months following the acute event, quantified via speckle tracking echocardiography. The study will include 400 patients diagnosed with acute myocardial infarction without signs and symptoms of heart failure at the time of enrollment that will undergo a complex clinical examination and speckle tracking echocardiography. Serum samples from the peripheral blood will be collected in order to determine the inflammatory serum biomarkers. After 6 months, patients will be divided into 2 groups according to the development of ventricular remodeling, quantified by speckle tracking echocardiography: group 1 will consist of patients with a remodeling index lower than 15%, and group 2 will consist of patients with a remodeling index higher than 15%. All clinical and imaging data obtained at the baseline will be compared between these two groups in order to determine the features associated with a higher risk of deleterious ventricular remodeling and heart failure.
INTroDUcTIoN
Heart failure is a clinical syndrome that appears as a consequence of a structural disease or a functional cardiac abnormality, with a negative prognosis, which affects annually between 0.4 and 2% of the European population. This prevalence has grown with the increase in the population's life expectancy, being one of the syndromes with a major importance in increasing the mortality and morbidity of patients. 1, 2 Chronic heart failure is determined by the inability of the heart to provide adequate cardiac output for the metabolic needs of the body or to ensure the adequate flow, at the cost of symptomatic increase of the heart filling pressures. 3 Although the causes of heart failure are multiple, the most common is left ventricular systolic dysfunction resulting from myocardial ischemia. The extension of myocardial injury is a major determinant of the severity of heart failure on both short-and long-term prognosis, producing geometrical changes in left ventricular conformation, both in the infarcted area and in the surrounding healthy tissue. The left ventricular remodeling process affects both ventricular function and survival rates. 4, 5 Cardiac remodeling and neuroendocrine activation are the major compensatory mechanisms that try, and sometimes manage, to restore the heart rate and organ perfusion, especially in essential organs. 6 The increase in the synthesis of vasodilator molecules (counter-regulation) in heart failure, including natriuretic peptides, NO, PGE2, bradykinin, and adrenomedullin, is followed by the emergence of resistance to their vasodilatory action. 7 In chronic heart failure, there is an increase in the production of pro-inflammatory cytokines that enhance neurohumoral activation and induce cardiomyocyte apoptosis and modification of the myocardial interstitial matrix with the growth of fibrous tissue. 7, 8 The increase of blood volume and of venous return is accompanied by increased ventricular filling pressures and increased parietal tension, which activate different genes in myocytes, including those involved in the synthesis of new myofibrils. 7, 9 This results in ventricular dilation, a heart compensation mechanism known as the Frank-Starling law. Dilatation of the ventricles leads to a more efficient interaction of actin filaments and myosin, which leads to a higher contraction force, but there is a limit of expansion beyond which the benefit disappears. 7, 9, 10 Ventricular remodeling is a consequence of increased parietal tension and neuroendocrine activity, with complex changes in the size, shape, and function of the left ventricle. 8, 9 Microscopically, the remodeling translates into myocardial hypertrophy, apoptosis and necrosis of some myocytes, and replacement by fibrous tissue, while macroscopically, changes are hypertrophy followed by dilation, both being major changes in ventricular geometry. 9 Therefore, the identification and quantification of post-ischemic ventricular remodeling is imperative in the treatment as well as in the management of this syndrome. 3, 11 One of the methods used for the examination of left ventricular function is speckle tracking echocardiography, a non-invasive method that tracks the movement of each speckle over a period of time, quantifying both regional and global heart function. By this technique, independent of the measurement angle, heart mechanics and left ventricular torsional motion can be assessed in all three planes (longitudinal, circumferential, and radial). All this information can be assessed for subsequent changes in ventricular kinetics. 12, 13 A speckle is a tissue marker that can be tracked frame by frame during the cardiac cycle. It has been compared to a fingerprint that is randomly found throughout the myocardium, which facilitates the calculation of radial, circumferential, and longitudinal myocardial deformation and tissue velocity, and torsion movements of the left ventricle. 14, 15 The serum values of the natriuretic peptides increase under increased ventricular loading conditions, thus illustrating the severity of heart failure. The serum level of natriuretic peptide B has been directly linked to the severity of heart failure symptoms and with the degree of left ventricular dysfunction, having also a significant prognostic value. Thus, natriuretic peptides represent reliable markers of heart failure, and can also predict the occurrence of this syndrome. [16] [17] [18] [19] [20] 
STUDY oBJEcTIVE
The main objective of the study is to identify the association between serum biomarkers illustrating the extent of myocardial necrosis (highly sensitive troponin assays), left ventricular dysfunction (NT-proBNP), and systemic inflammatory response (illustrated via serum levels of hsCRP and interleukins) during the acute phase of a myocardial infarction, and the left ventricular remodeling process at 6 months following the acute event, quantified via speckle tracking echocardiography.
METHoDS

Study population
This will be a prospective, non-randomized, clinical follow-up of patients over a 1-year period that will include 400 patients diagnosed with acute myocardial infarction without signs and symptoms of heart failure at the time of enrollment, or with a history of heart failure, admitted under emergency conditions to the Clinic of Cardiology of the Emergency Clinical County Hospital of Târgu Mureș.
Inclusion and exclusion criteria
Eligible patients should be aged 18 years old or over, and have suffered an acute myocardial infarction (with and without ST segment elevation -STEMI/NSTEMI) within the past 7 days before enrollment, confirmed with 12-lead ECG tracings, imaging, and enzymes, with no signs and symptoms of heart failure at the time of presentation, with no history of heart failure or previous myocardial infarction.
Exclusion criteria will be the absence of serum evidence of myocardial necrosis, confirmed diagnosis of acute myocardial infarction and/or history of heart failure at more than 7 days after the ischemic episode, patient refusal.
Study groups
The study group will consist of 400 patients with acute myocardial infarction who will undergo a complex clinical examination and speckle tracking imaging. Serum samples from the peripheral blood will be collected in order to determine serum inflammatory biomarkers.
Follow-up protocol
Patients will be clinically monitored at one month and 6 months using speckle tracking echocardiography, to assess the evolution of left ventricular remodeling and wall motion following the ischemic episode. According to their remodeling index, patients will be divided into 2 groups: group 1 will consist of patients with a remodeling index lower than 15%, and group 2 will consist of patients with a remodeling index higher than 15%. All clinical and imaging data obtained at the baseline will be compared between the two groups in order to determine the features associated with a higher risk of deleterious ventricular remodeling and heart failure.
Study procedures
The following data will be collected and processed in a dedicated electronic database: 
DIScUSSIoNS
Studies on predictable factors for left ventricular remodeling post myocardial infarction are really valuable, for instance, in establishing the therapeutic approach of the patient with heart failure. The main modalities of ventricular remodeling -concentric (by pressure overload), eccentric, dilated (excessive volume), and mixed (especially after myocardial infarction when the first two conditions are associated) -lead, in time, to heart failure with systolic dysfunction. This can be prevented by a prompt, fast, and early intervention, starting from the concept of reverseremodeling introduced by Kass in 1995 and revised in 2012 with Koitabashi. 21, 22 It is known that left ventricular remodeling can be reversible by putting the heart in induced arrest for a period of time with the help of an artificial heart as an extended mechanical support or with pharmacological therapies -beta blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and mineralocorticoid receptor inhibitors. Therefore, these modalities, or other that are still under research (stem cell therapies, ventriculoplasty, diastolic contention devices), will be able to recover the longterm systolic function of the left ventricle. 11, 23 This study is designed to investigate the relationship between the systemic inflammatory response during the acute phase of an acute myocardial infarction, and the left ventricular remodeling process, as illustrated by speckle tracking echocardiography, at 6 months after the index event, in patients without previously diagnosed heart failure or ischemic heart disease.
coNcLUSIoNS
The study will identify clinical, serum, and imaging features that can predict adverse ventricular remodeling and heart failure in patients with myocardial infarction, in order to initiate the optimal treatment that could regress the evolution towards heart failure in subjects at high risk for adverse remodeling.
